Literature DB >> 15201705

Aerosolized tissue plasminogen inhibitor improves pulmonary function in sheep with burn and smoke inhalation.

Perenlei Enkhbaatar1, Kazunori Murakami, Robert Cox, Martin Westphal, Naoki Morita, Kimberly Brantley, Ann Burke, Hal Hawkins, Frank Schmalstieg, Lillian Traber, David Herndon, Daniel Traber.   

Abstract

Acute respiratory distress syndrome is a major complication in patients with thermal injury. The obstruction of the airway by cast material, composed in part of fibrin, contributes to deterioration of pulmonary gas exchange. We tested the effect of aerosol administration of tissue plasminogen activator, which lyses fibrin clots, on acute lung injury in sheep that had undergone combined burn/smoke inhalation injury. Anesthetized sheep were given a 40% total body surface, third degree burn and were insufflated with cotton smoke. Tissue plasminogen activator (TPA) was nebulized every 4 h at 1 or 2 mg for each nebulization, beginning 4 h after injury. Injured but untreated control sheep developed multiple symptoms of acute respiratory distress syndrome: decreased pulmonary gas exchange, increased pulmonary edema, and extensive airway obstruction. These control animals also showed increased pulmonary transvascular fluid flux and increased airway pressures. These variables were all stable in sham animals. Nebulization of saline or 1 mg of TPA only slightly improved measures of pulmonary function. Treatment of injured sheep with 2 mg of TPA attenuated all the pulmonary abnormalities noted above. The results provide evidence that clearance of airway obstructive cast material is crucial in managing acute respiratory distress syndrome resulting from combined burn and smoke inhalation injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201705     DOI: 10.1097/01.shk.0000129201.38588.85

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  32 in total

1.  Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury.

Authors:  Matthias Lange; Csaba Szabo; Perenlei Enkhbaatar; Rhykka Connelly; Eszter Horvath; Atsumori Hamahata; Robert A Cox; Aimalohi Esechie; Yoshimitsu Nakano; Lillian D Traber; David N Herndon; Daniel L Traber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-12       Impact factor: 5.464

Review 2.  [Inhalation injury--epidemiology, diagnosis and therapy].

Authors:  Ulrich Thaler; Paul Kraincuk; Lars-Peter Kamolz; Manfred Frey; Philipp G H Metnitz
Journal:  Wien Klin Wochenschr       Date:  2010-01       Impact factor: 1.704

3.  Feasibility of tissue plasminogen activator formulated for pulmonary delivery.

Authors:  John S Dunn; Rajiv Nayar; Jackie Campos; Brooks M Hybertson; Yue Zhou; Mark Cornell Manning; John E Repine; Kathleen A Stringer
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

4.  Inhibition of lung permeability changes after burn and smoke inhalation by an anti-interleukin-8 antibody in sheep.

Authors:  Hiroyuki Sakurai; Kazutaka Soejima; Frank C Schmalstieg; Motohiro Nozaki; Daniel L Traber
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

Review 5.  Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Authors:  Hunter B Moore; Ernest E Moore; Matthew D Neal; Forest R Sheppard; Lucy Z Kornblith; Dominik F Draxler; Mark Walsh; Robert L Medcalf; Mitch J Cohen; Bryan A Cotton; Scott G Thomas; Christine M Leeper; Barbara A Gaines; Angela Sauaia
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

6.  Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction.

Authors:  Livia A Veress; Tara B Hendry-Hofer; Joan E Loader; Jacqueline S Rioux; Rhonda B Garlick; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-04       Impact factor: 6.914

Review 7.  [Pathophysiology of acute lung injury in severe burn and smoke inhalation injury].

Authors:  M O Maybauer; S Rehberg; D L Traber; D N Herndon; D M Maybauer
Journal:  Anaesthesist       Date:  2009-08       Impact factor: 1.041

8.  Tissue factor signals airway epithelial basal cell survival via coagulation and protease-activated receptor isoforms 1 and 2.

Authors:  Shama Ahmad; Aftab Ahmad; Raymond C Rancourt; Keith B Neeves; Joan E Loader; Tara Hendry-Hofer; Jorge Di Paola; Susan D Reynolds; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-11       Impact factor: 6.914

9.  Advantages and pitfalls of combining intravenous antithrombin with nebulized heparin and tissue plasminogen activator in acute respiratory distress syndrome.

Authors:  Sebastian Rehberg; Yusuke Yamamoto; Linda E Sousse; Collette Jonkam; Robert A Cox; Donald S Prough; Perenlei Enkhbaatar
Journal:  J Trauma Acute Care Surg       Date:  2014-01       Impact factor: 3.313

10.  Pharmaco-management of inhalation injuries for burn survivors.

Authors:  Anthony C Bartley; Dale W Edgar; Fiona M Wood
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.